Literature DB >> 10533725

Correlation of clinical features and telomerase activity in human gliomas.

F Huang1, H Kanno, I Yamamoto, Y Lin, Y Kubota.   

Abstract

Telomerase is a ribonucleoprotein containing an RNA template that synthesizes telomeric DNA. The expression of telomerase activity is concomitant with the attainment of immortality in tumor tissues and cells. In this report, we analyzed telomerase activity in 39 human gliomas with different histological, and in 10 meningiomas, 3 neurinomas, and 2 normal brain tissues by using a polymerase chain reaction (PCR)-based telomeric repeat amplification protocol (TRAP) assay. Telomerase activity was detectable in almost all of the gliomas (36 of 39), but not in any of the meningiomas, neurinomas, or normal brain tissues. In addition, we also analyzed the level of telomerase activity in the 36 gliomas with positive telomerase activity. The relative telomerase activity of the glioma showed a clear association with the pathological grade of glioma; i.e., most of the tumors with high telomerase activity were pathologically of high grade. And also the relative level of telomerase activity could be correlated with the survival time of the patients. These results suggest that the level of telomerase activity in brain tumors is a diagnostic marker indicating the prognosis of the patient as well as the malignant potential of the tumor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10533725     DOI: 10.1023/a:1006258817785

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  21 in total

1.  Telomerase activity in human gliomas.

Authors:  S Le; J J Zhu; D C Anthony; C W Greider; P M Black
Journal:  Neurosurgery       Date:  1998-05       Impact factor: 4.654

2.  Functional characterization and developmental regulation of mouse telomerase RNA.

Authors:  M A Blasco; W Funk; B Villeponteau; C W Greider
Journal:  Science       Date:  1995-09-01       Impact factor: 47.728

Review 3.  Telomeres: beginning to understand the end.

Authors:  V A Zakian
Journal:  Science       Date:  1995-12-08       Impact factor: 47.728

4.  Telomerase activity in candidate stem cells from fetal liver and adult bone marrow.

Authors:  J Yui; C P Chiu; P M Lansdorp
Journal:  Blood       Date:  1998-05-01       Impact factor: 22.113

5.  The significant role of telomerase activity in human brain tumors.

Authors:  K Nakatani; N Yoshimi; H Mori; S Yoshimura; H Sakai; J Shinoda; N Sakai
Journal:  Cancer       Date:  1997-08-01       Impact factor: 6.860

6.  Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age.

Authors:  H Vaziri; W Dragowska; R C Allsopp; T E Thomas; C B Harley; P M Lansdorp
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

7.  Telomere length predicts replicative capacity of human fibroblasts.

Authors:  R C Allsopp; H Vaziri; C Patterson; S Goldstein; E V Younglai; A B Futcher; C W Greider; C B Harley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

8.  Correlating telomerase activity levels with human neuroblastoma outcomes.

Authors:  E Hiyama; K Hiyama; T Yokoyama; Y Matsuura; M A Piatyszek; J W Shay
Journal:  Nat Med       Date:  1995-03       Impact factor: 53.440

9.  Specific association of human telomerase activity with immortal cells and cancer.

Authors:  N W Kim; M A Piatyszek; K R Prowse; C B Harley; M D West; P L Ho; G M Coviello; W E Wright; S L Weinrich; J W Shay
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

10.  Telomerase activity in human bladder cancer.

Authors:  Y Lin; H Miyamoto; K Fujinami; H Uemura; M Hosaka; Y Iwasaki; Y Kubota
Journal:  Clin Cancer Res       Date:  1996-06       Impact factor: 12.531

View more
  11 in total

1.  Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results.

Authors:  Ali Chahlavi; Andrew Kanner; David Peereboom; Susan M Staugaitis; Paul Elson; Gene Barnett
Journal:  J Neurooncol       Date:  2003-02       Impact factor: 4.130

2.  Experimental Curative Fluorescence-guided Surgery of Highly Invasive Glioblastoma Multiforme Selectively Labeled With a Killer-reporter Adenovirus.

Authors:  Shuya Yano; Shinji Miwa; Hiroyuki Kishimoto; Makoto Toneri; Yukihiko Hiroshima; Mako Yamamoto; Michael Bouvet; Yasuo Urata; Hiroshi Tazawa; Shunsuke Kagawa; Toshiyoshi Fujiwara; Robert M Hoffman
Journal:  Mol Ther       Date:  2015-04-21       Impact factor: 11.454

3.  A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.

Authors:  Trent R Hummel; Ralph Salloum; Rachid Drissi; Shiva Kumar; Matthew Sobo; Stewart Goldman; Ahna Pai; James Leach; Adam Lane; David Pruitt; Mary Sutton; Lionel M Chow; Laurie Grimme; Renee Doughman; Lori Backus; Lili Miles; Charles Stevenson; Maryam Fouladi; Mariko DeWire
Journal:  J Neurooncol       Date:  2015-12-01       Impact factor: 4.130

4.  Commentary: Evaluating potential glioma serum biomarkers, with future applications.

Authors:  Michael Goutnik; Brandon Lucke-Wold
Journal:  World J Clin Oncol       Date:  2022-05-24

Review 5.  Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies.

Authors:  Trent R Hummel; Lionel M Chow; Maryam Fouladi; David Franz
Journal:  Paediatr Drugs       Date:  2013-02       Impact factor: 3.022

6.  Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas.

Authors:  Kathleen Dorris; Matthew Sobo; Arzu Onar-Thomas; Eshini Panditharatna; Charles B Stevenson; Sharon L Gardner; Mariko D Dewire; Christopher R Pierson; Randal Olshefski; Sandra A Rempel; Stewart Goldman; Lili Miles; Maryam Fouladi; Rachid Drissi
Journal:  J Neurooncol       Date:  2014-01-30       Impact factor: 4.130

7.  The telomerase antagonist, imetelstat, efficiently targets glioblastoma tumor-initiating cells leading to decreased proliferation and tumor growth.

Authors:  Calin O Marian; Steve K Cho; Brian M McEllin; Elizabeth A Maher; Kimmo J Hatanpaa; Christopher J Madden; Bruce E Mickey; Woodring E Wright; Jerry W Shay; Robert M Bachoo
Journal:  Clin Cancer Res       Date:  2010-01-01       Impact factor: 12.531

8.  Telomerase detection in the diagnosis and prognosis of cancer.

Authors:  Eiso Hiyama; Keiko Hiyama
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

9.  mRNA quantification and clinical evaluation of telomerase reverse transcriptase subunit (hTERT) in intracranial tumours of patients in the island of Crete.

Authors:  A Yannopoulos; E Dimitriadis; A Scorilas; T Trangas; E Markakis; M Talieri
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640

10.  Clinical implications of quantitative real-time RT-PCR analysis of hTERT gene expression in human gliomas.

Authors:  A Tchirkov; C Rolhion; J-L Kémény; B Irthum; S Puget; T Khalil; O Chinot; F Kwiatkowski; B Périssel; P Vago; P Verrelle
Journal:  Br J Cancer       Date:  2003-02-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.